Computerized Self-help Treatment for Primary Insomnia

描述(申请人提供)：尽管近15%的成年人经历过慢性原发失眠，但很少有人寻求或获得针对这种情况的有效行为治疗。这个项目的目的是设计、开发和评估一种计算机化的自助干预，提供全面的失眠行为治疗。失眠评估和治疗计划(IATP)的第一阶段原型被开发出来，该计划使用主动睡眠采样程序评估睡眠和觉醒状态，然后实施刺激控制和睡眠限制干预。最终的原型对86名受试者进行了评估，将IATP与只提供监测和教育治疗组件的对照组进行了比较。尽管对照组的活性成分很多，但IATP条件在试验期间评估的大多数睡眠参数上都有明显的改善。对于第二阶段，该方案将在特定目的平台上重新设计和重新开发。该计划将在200名慢性原发性失眠症患者的随机对照试验中进行评估，将IATP治疗计划与一本治疗失眠的自助行为治疗书进行比较，并将IATP设备仅用于监测目的。受试者将在基线以及第7、14和28周根据睡眠日记和睡眠质量、效率和损害的自我报告数据进行评估。在基线和14周时，还将对样本的一部分进行以家庭为基础的多夜多导睡眠监测。该项目的结果可能会产生一种经过经验验证的失眠行为疗法，数百万患有慢性原发性失眠的人很容易获得这种疗法。

DESCRIPTION (provided by applicant): Although nearly 15 percent of adults experience chronic primary insomnia, few have sought or have access to effective behavioral treatments for this condition. The purpose of this project is to design, develop, and evaluate a computerized self-help intervention that provides a comprehensive behavioral treatment of insomnia. A Phase I prototype of the Insomnia Assessment and Treatment Program (IATP) was developed which assessed sleep and wake states using an active sleep sampling procedures and then implemented a stimulus control and sleep restriction intervention. The resulting prototype was evaluated with 86 subjects, comparing the IATP to a comparison group provided with monitoring and educational treatment components only. Despite the active components of the comparison group, the IATP condition produced superior improvement on most of the sleep parameters evaluated during the trial. For Phase II, the program will be redesigned and redeveloped on a specific purpose platform. The program will be evaluated in a randomized controlled trial of 200 subjects with chronic primary insomnia, comparing the IATP treatment program to a self-help behavioral treatment book for insomnia and the IATP device for monitoring purposes only. Subjects will be evaluated at baseline and at weeks 7, 14, and 28 on sleep diary and self-report data of sleep quality, efficiency, and impairment. Home-based, multi-night polysomnography also will be performed on a subset of the sample at baseline and at 14 weeks. The results of this project could produce an empirically validated behavioral treatment for insomnia, which is easily accessed by the millions of people suffering from chronic primary insomnia.